Identifying patients with non-valvular atrial fibrillation & poorly controlled INR on warfarin who are suitable to be switched to NOACs

被引:0
|
作者
Ahmad, H. N. [1 ]
Van Staden, B. [1 ]
Haque, A. [1 ]
Khan, A. [1 ]
Gul, A. [1 ]
机构
[1] Burton Hosp NHS Fdn Trust, Dept Haematol, Burton Upon Trent, Staffs, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
92
引用
收藏
页码:41 / 41
页数:1
相关论文
共 50 条
  • [1] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [2] Assessing the Clinical Characteristics of Non-Valvular Atrial Fibrillation Patients Who are Uncontrolled on Warfarin
    Lowenkopf, Theodore
    Stuchiner, Tamela
    Corless, Leslie
    Hartaigh, Briain O.
    Baraban, Elizabeth
    [J]. NEUROLOGY, 2021, 96 (15)
  • [3] Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
    Winnie W. Nelson
    Li Wang
    Onur Baser
    Chandrasekharrao V. Damaraju
    Jeffrey R. Schein
    [J]. International Journal of Clinical Pharmacy, 2015, 37 : 53 - 59
  • [4] Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Wang, Li
    Baser, Onur
    Damaraju, Chandrasekharrao V.
    Schein, Jeffrey R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 53 - 59
  • [5] Comparison of healthcare costs among patients with non-valvular atrial fibrillation treated with warfarin who switched to a novel oral anticoagulant
    Franchino-Elder, Jessica
    Gilligan, Adrienne
    Song, Xue
    Hartaigh, Briain O.
    Henriques, Caroline
    Sainski-Nguyen, Amy
    Wang, Cheng
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2020, 11 (02) : 133 - 140
  • [6] Barriers to using warfarin in non-valvular atrial fibrillation
    Gattellari, M
    Zwar, NA
    Worthington, JM
    Middleton, S
    [J]. BRITISH MEDICAL JOURNAL, 2006, 332 (7536): : 303 - 304
  • [7] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [8] DISCONTINUATION/INTERRUPTION OF WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A763 - A763
  • [9] Comparative Effectiveness of Dabigatran versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Alonso, Alvaro
    Chen, Lin Y.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    [J]. CIRCULATION, 2013, 128 (22)
  • [10] WARFARIN DISCONTINUATION AND STROKE RISK AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A8 - A9